...Chester Carlson was a patent agent who tired of having to make multiple copies of patent applications using the only duplication method available at the time: carbon paper. In 1959 he came up with a new copying system and took it to IBM for evaluation. The "experts" at IBM determined potential sales to be only 5,000 units because people wouldn't want to use a bulky machine when they had carbon paper. Carlson's invention was the xerography process, the company founded on the system is Xerox.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7985597 | Process and apparatus for providing a gaseous substance for the analysis of chemical elements or compounds The invention relates to a process and to an apparatus for providing a gaseous substance for the analysis of chemical elements or compounds. In one embodiment, a starting substance is continuously admixed with a reagent substance. This results in a gaseous reaction ... | 07/26/2011 |
| 7960342 | Receptor(SSTR2)-selective somatostatin antagonists SRIF peptide antagonists, which are selective for SSTR2 in contrast to the other cloned SRIF receptors and which bind with high affinity to the cloned human receptor SSTR2 but do not activate the receptor, have many useful functions. Because they do not bind with si... | 06/14/2011 |
| 7851197 | Exoenzyme toxin of , and uses therefor A protein toxin named Aeromonas salmonicida exoenzyme T (AexT), which belongs to the family of ADP-ribosylating toxins, is disclosed as is a novel Calcium (or other cation concentration) dependent promoter of A. salmonicida. Also disclosed are diagnost... | 12/14/2010 |
| 7815896 | Type III secretion pathway in and uses therefor Disclosed is a newly identified and characterized type III secretion system in Aeromonas salmonicida. The invention also encompasses the use of components of the novel secretion system in immunoprotection against A. salmonicida infection, as well as ot... | 10/19/2010 |
| 7656572 | Method, array, and influencing unit for said array in order to modify a wavefront of an optical beam Disclosed is an array for modifying a wavefront of an optical beam (3) having a beam axis (15). Said array comprises an influencing unit (1) which can be introduced into the beam path of the optical beam (3) and a heat source (12) ... | 02/02/2010 |
| 7655300 | Transparent zeolite-polymer hybrid material with tunable properties The invention is about the preparation of novel highly transparent zeolite-doped polymer and zeolites monolayers. External coating of the zeolite crystals by covalently linked functionalized alkoxysilane derivatives allows for an efficient dispersion of the n... | 02/02/2010 |
| 7579011 | Exoenzyme toxin of , and uses therefor A novel protein toxin named Aeromonas salmonicida exoenzyme T (AexT), which belongs to the family of ADP-ribosylating toxins, is disclosed as is a novel Calcium (or other cation concentration) dependent promoter of A. salmonicida. Also disclosed are di... | 08/25/2009 |
| 7538208 | Type III secretion pathway in , and uses therefor Disclosed is a newly identified and characterized type III secretion system in Aeromonas salmonicida. The invention also encompasses the use of components of the novel secretion system in immunoprotection against A. salmonicida infection, as well as ot... | 05/26/2009 |
| 7351550 | Exoenzyme toxin of , and uses thereof A protein toxin named Aeromonas salmonicida exoenzyme T (AcxT), which belongs to the family of ADP-ribosylating toxins, is disclosed as is a Calcium (or other cation concentration) dependent promoter of A. salmonicida. Also disclosed are diagnostic, pr... | 04/01/2008 |
| 7232569 | Type III secretion pathway in , and uses therefor Disclosed is a newly identified and characterized type III secretion system in Aeromonas salmonicida. The invention also encompasses the use of components of the novel secretion system in immunoprotection against A. salmonicida infection, as well as ot... | 06/19/2007 |
| 6932919 | Dye loaded zeolite material The present invention provides a dye loaded zeolite material comprising: a) at least one zeolite crystal having straight through uniform channels each having a channel axis parallel to, and a channel width transverse to, a c-axis of crystal unit cells; b) closure mo... | 08/23/2005 |
| 6888859 | Compensation of thermal optical effects A method for compensating thermal optical effects in the beam path of an arrangement containing optical components uses, for the purpose of optical compensation in the beam path, optical elements which have different material properties in cooperation. For the purpo... | 05/03/2005 |
| 6858236 | Plant extracts for the treatment of increased bone resorption The present invention is concerned with nutritional or pharmaceutical compositions containing an extract or concentrate of a plant from the genus Lycopersicon. The compositions of the invention are useful for the treatment or prophylaxis of diseases or condit... | 02/22/2005 |
| 6754249 | Laser resonator for generating polarized laser radiation A method for generating polarized laser output radiation utilizes a laser resonator whose active medium exhibits thermally induced birefringence. The radiation fields oscillating in the laser resonator are not subjected to polarization selection, and only the radiat... | 06/22/2004 |
| 6638540 | Plant extracts for the treatment of increased bone resorption The present invention is concerned with nutritional or pharmaceutical compositions containing a plant extract or concentrate selected from the group consisting of allium (leek), aethusa (dog parsley), petroselium (parsley) and brassica (cabbage) extracts ... | 10/28/2003 |
| 6534098 | Plant extracts for the treatment of increased bone resorption The present invention is concerned with nutritional or pharmaceutical compositions containing an extract or concentrate of a plant from the genus anethum. The compositions of the invention are useful for the treatment or prophylaxis of diseases or conditi... | 03/18/2003 |